跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
NIVOLUMAB BMS CONCENTRATE FOR SOLUTION FOR INFUSION 10MG/ML - HSA Drug Approval Details
Approvals
/
HSA
/
NIVOLUMAB BMS CONCENTRATE FOR SOLUTION FOR INFUSION 10MG/ML
Approved
THERAPEUTIC
NIVOLUMAB BMS CONCENTRATE FOR SOLUTION FOR INFUSION 10MG/ML
Bristol-Myers Squibb Holdings Pharma, Ltd. Liability Company (UNITED STATES)
🇸🇬 Health Sciences Authority
Approval Date
Nov 9, 2016
Approval ID
c667fa35e224641d
Company
Bristol-Myers Squibb Holdings Pharma, Ltd. Liability Company (UNITED STATES)
Type
Therapeutic
Approval Details
Approval Id
c667fa35e224641d
Drug Name
NIVOLUMAB BMS CONCENTRATE FOR SOLUTION FOR INFUSION 10MG/ML
Product Name
NIVOLUMAB BMS CONCENTRATE FOR SOLUTION FOR INFUSION 10MG/ML
Approval Number
SIN15117P
Approval Date
2016-11-09
Registrant
BRISTOL-MYERS SQUIBB (SINGAPORE) PTE. LTD.
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
INFUSION, SOLUTION CONCENTRATE
Route Of Administration
INTRAVENOUS DRIP
Atc Code
L01XC17
Atc Item Name
xl 01 xc 17
Pharma Manufacturer Name
BRISTOL-MYERS SQUIBB (SINGAPORE) PTE. LTD.
Active Ingredients
Nivolumab
10 mg/mL
Nivolumab
10 mg/mL
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Nov 9, 2016
Approval ID
c667fa35e224641d
Type
Therapeutic
Back to HSA Approvals
